Published in Medical Devices and Surgical Technology Week, November 21st, 2004
"These data are further evidence that Actonel provides fracture risk reduction across a broad range of postmenopausal women with osteoporosis, even those prone to experiencing GI side effects," said Karen Hansen, assistant professor of medicine, Rheumatology Division, University of Wisconsin Department of Medicine and chief of rheumatology, VA Hospital, Madison,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Devices and Surgical Technology Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.